R&D PIPELINE

LS205

Chemical Drug under China Categories 2.2 + 2.4

A new drug developed on the basis of real-world evidence for neurological treatment, addressing an unmet treatment need in China and internationally.

Expanding treatment availability and supporting quality of life in older populations.